Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrosclerotherapy for Capillary Malformations
NCT02883023Phase 2Unknown
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in capillary malformation (CM). Status: unknown.
02
Drugs
bleomycin
03
Conditions
capillary malformation (CM)
Beyond the preview
Go deeper on NCT02883023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02883023.